🇱🇰 Chapter 30 — Pharmaceutical Products Trade with Sri Lanka
Export and import data for Indian businesses
$263.0M
Exports to Sri Lanka (2024)
$3.0M
Imports from Sri Lanka (2024)
6
HS Headings Traded
🇱🇰 Sri Lanka — Country Profile
Capital
Colombo
GDP (USD)
$75.00
Population
22.2M
Currency
Sri Lankan Rupee
Trade Agreement
SAFTA, APTA
HS Heading Breakdown — Chapter 30
| HS Code | Description | Export (USD) | Import (USD) |
|---|---|---|---|
| 3004 | Medicaments (excluding Goods Of Heading 3002, 3005 Or 3006) Consisting Of Mixed Or Unmixed Products For Therapeutic Or Prophylactic Uses, Put Up In Measured Doses (including Those In The Form Of Transdermal Administration Systems) Or In Forms Or Packings | $194.3M | $0 |
| 3002 | Human Blood; Animal Blood Prepared Fortherapeutic, Prophylactic Or Diagnostic Uses; Antisera, Other Blood Fractions And Immunological Products, Whether Or Not Modified Or Obtained By Means Of Biotechnological Processes; Vaccines,toxins, Cultures Of Micro- | $41.5M | $3.0M |
| 3003 | Medicaments (excluding Goods Of Heading 3002, 3005 Or 3006) Consisting Of Two Or More Constituents Which Have Been Mixed Together For Therapeutic Or Prophylactic Uses, Not Put Up In Measured Doses Or In Forms Or Packings For Retail Sale | $15.5M | $0 |
| 3006 | Pharmaceutical goods specified in note 4 to this chapter | $6.0M | $0 |
| 3001 | Glands And Other Organs For Organo- Therapeutic Uses, Dried,whether Or Not Powdered; Extracts Of Glands Or Other Organs Or Of Their Secretions For Organo- Therapeutic Uses; Heparin And Its Salts; Other Human Or Animal Substances Prepared For Therapeutic O | $3.4M | $0 |
| 3005 | Wadding, Gauze, Bandages And Similar Articles (for Example, Dressings, Adhesive Plasters, Poultices), Impregnated Or Coated With Pharmaceutical Substances Or Put Up In Forms Or Packings For Retail Sale For Medical, Surgical, Dental Or Veterinary Purposes | $2.3M | $460 |
Other Trading Partners for Chapter 30
Trade in Pharmaceutical Products with Sri Lanka
Get detailed market intelligence and export guidance.